Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SurModics: Fiscal Q1 Earnings Snapshot AP - Thu Feb 1, 6:11AM CST

SurModics: Fiscal Q1 Earnings Snapshot

SRDX : 26.17 (+0.38%)
SurModics: Fiscal Q4 Earnings Snapshot AP - Wed Nov 8, 2023

SurModics: Fiscal Q4 Earnings Snapshot

SRDX : 26.17 (+0.38%)
SurModics: Fiscal Q3 Earnings Snapshot AP - Wed Aug 2, 2023

SurModics: Fiscal Q3 Earnings Snapshot

SRDX : 26.17 (+0.38%)
Why Shares of Surmodics Jumped This Week Motley Fool - Fri Jun 23, 2023

The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.

SRDX : 26.17 (+0.38%)
Why Shares of Surmodics Soared on Tuesday Motley Fool - Tue Jun 13, 2023

An analyst upgrade gave the stock a boost.

SRDX : 26.17 (+0.38%)
Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised Zacks - Thu Apr 27, 2023

Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.

JNJ : 146.82 (-1.15%)
ISRG : 373.12 (-0.50%)
EW : 88.01 (-0.68%)
SRDX : 26.17 (+0.38%)
SurModics (SRDX) Reports Q2 Loss, Tops Revenue Estimates Zacks - Wed Apr 26, 2023

SurModics (SRDX) delivered earnings and revenue surprises of 18.37% and 4.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SRDX : 26.17 (+0.38%)
PODD : 164.17 (-1.84%)
SurModics: Fiscal Q2 Earnings Snapshot AP - Wed Apr 26, 2023

SurModics: Fiscal Q2 Earnings Snapshot

SRDX : 26.17 (+0.38%)
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance Business Wire - Wed Apr 26, 2023

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March...

SRDX : 26.17 (+0.38%)
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System Business Wire - Thu Apr 20, 2023

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first patient in PROWL, the Pounce™ Thrombectomy System Retrospective...

SRDX : 26.17 (+0.38%)

Barchart Exclusives

Guess vs. Levi Strauss: Which Breakout Dividend Stock Is a Better Buy? Barchart - 1 hour ago
With Levi Strauss and Guess stock prices surging and both apparel giants impressing shareholders with their dividend payments, which of the two is a better buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot